- Home
- Publications
- Publication Search
- Publication Details
Title
Can we prevent BRCA1-associated breast cancer by RANKL inhibition?
Authors
Keywords
<em class=EmphasisTypeItalic >BRCA</em>, Breast cancer, RANKL, Prevention, Denosumab
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 161, Issue 1, Pages 11-16
Publisher
Springer Nature
Online
2016-10-25
DOI
10.1007/s10549-016-4029-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study
- (2016) Joanne Kotsopoulos et al. BREAST CANCER RESEARCH AND TREATMENT
- RANKL/RANK control Brca1 mutation-driven mammary tumors
- (2016) Verena Sigl et al. CELL RESEARCH
- Bilateral Oophorectomy and Breast Cancer Risk inBRCA1andBRCA2Mutation Carriers
- (2016) Joanne Kotsopoulos et al. JNCI-Journal of the National Cancer Institute
- RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers
- (2016) Emma Nolan et al. NATURE MEDICINE
- Bilateral Oophorectomy and Breast Cancer Risk inBRCA1andBRCA2Mutation Carriers
- (2016) Joanne Kotsopoulos et al. JNCI-Journal of the National Cancer Institute
- The RANKL-RANK Story
- (2015) Vanja Nagy et al. GERONTOLOGY
- Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
- (2015) Michael Gnant et al. LANCET
- RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDIN1
- (2015) Purna A. Joshi et al. Stem Cell Reports
- Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone
- (2015) Rowan T. Chlebowski et al. JAMA Oncology
- Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
- (2015) Martin Widschwendter et al. EBioMedicine
- Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
- (2014) Jacek Gronwald et al. BREAST CANCER RESEARCH AND TREATMENT
- Serum osteoprotegerin and future risk of cancer and cancer-related mortality in the general population: the Tromsø study
- (2014) Anders Vik et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
- (2014) Amy P.M. Finch et al. JOURNAL OF CLINICAL ONCOLOGY
- Health care provider recommendations for reducing cancer risks among women with aBRCA1orBRCA2mutation
- (2013) KA Metcalfe et al. CLINICAL GENETICS
- Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2013) Kelly-Anne Phillips et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
- (2013) Nasim Mavaddat et al. JNCI-Journal of the National Cancer Institute
- Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women’s Health Initiative Observational Study
- (2013) Rowan T. Chlebowski et al. JNCI-Journal of the National Cancer Institute
- Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
- (2012) N. Mavaddat et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Denosumab: mechanism of action and clinical outcomes
- (2012) D. A. Hanley et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
- (2012) Garnet L Anderson et al. LANCET ONCOLOGY
- Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
- (2011) Kelly Metcalfe et al. BREAST CANCER RESEARCH AND TREATMENT
- Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
- (2011) K Metcalfe et al. BRITISH JOURNAL OF CANCER
- The risk of breast cancer in women with a BRCA1 mutation from North America and Poland
- (2011) Jan Lubinski et al. INTERNATIONAL JOURNAL OF CANCER
- Pathology of hereditary breast cancer
- (2010) Leonard Da Silva et al. MODERN PATHOLOGY
- RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
- (2010) Eva Gonzalez-Suarez et al. NATURE
- Control of mammary stem cell function by steroid hormone signalling
- (2010) Marie-Liesse Asselin-Labat et al. NATURE
- Progesterone induces adult mammary stem cell expansion
- (2010) Purna A. Joshi et al. NATURE
- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
- (2010) Daniel Schramek et al. NATURE
- BRCA mutations in the management of breast cancer: the state of the art
- (2010) Steven A. Narod Nature Reviews Clinical Oncology
- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
- (2009) Elgene Lim et al. NATURE MEDICINE
- International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
- (2008) Kelly A. Metcalfe et al. INTERNATIONAL JOURNAL OF CANCER
- Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study
- (2008) Noah D. Kauff et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started